51 – 60 of 162
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Editorial : Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
- Contribution to journal › Debate/Note/Editorial
-
Mark
Editorial : Current challenges in complement diagnostics
- Contribution to journal › Debate/Note/Editorial
-
Mark
Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus : a case report
- Contribution to journal › Article
-
Mark
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
- Contribution to journal › Article
- 2022
-
Mark
The Hidden Side of Complement Regulator C4BP : Dissection and Evaluation of Its Immunomodulatory Activity
- Contribution to journal › Article
-
Mark
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
- Contribution to journal › Article
-
Mark
Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation
- Contribution to journal › Article
-
Mark
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
- Contribution to journal › Article
-
Mark
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia
- Contribution to journal › Article
-
Mark
Antigen-Presenting B Cells Program the Efferent Lymph T Helper Cell Response
- Contribution to journal › Article
